![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
ONYX-I: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Asian Adults with Genotype 1b Chronic Hepatitis C Virus Infection - A Randomized, Double-Blind, Placebo-Controlled Study
|
|
|
Reported by Jules Levin
26th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Shanghai, China. 16-19 Feb 2017
Lai Wei1, Jinlin Hou2, Yan Luo3, Jeong Heo4, Chi-Jen Chu5, Zhongping Duan6, Mong Cho7, Jun Cheng8, Jun Li9, Jidong Jia10, Wenjing Lu3, Tami Pilot-Matias3, Sarah Kopecky-Bromberg3, Niloufar Mobashery3, and Wan-Long Chuang11
1Peking University Peoples Hospital, Beijing; 2Nanfang Hospital, Guangzhou; 3AbbVie Inc., North Chicago, IL; 4Department of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Pusan National University Hospital, Busan; 5Taipei Veterans General Hospital, Taipei City; 6Beijing Youan Hospital Capital Medical University, Beijing; 7Pusan National University Yangsan Hospital, Yangsan; 8Beijing Di Tan Hospital, Capital Medical University, Beijing; 9Jiangsu Province Hospital, Nanjing, Jiangsu Province; 10Beijing Friendship Hospital, Capital Medical University, Beijing; 11Kaohsiung Medical University, Kaohsiung City
![CROI1](../images/031417/031417-1/CROI1.gif)
![CROI2](../images/031417/031417-1/CROI2.gif)
![CROI3](../images/031417/031417-1/CROI3.gif)
![CROI4](../images/031417/031417-1/CROI4.gif)
![CROI5](../images/031417/031417-1/CROI5.gif)
![CROI6](../images/031417/031417-1/CROI6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|